Kendall Walsh

413 total citations
16 papers, 297 citations indexed

About

Kendall Walsh is a scholar working on Surgery, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Kendall Walsh has authored 16 papers receiving a total of 297 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 6 papers in Oncology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Kendall Walsh's work include Breast Cancer Treatment Studies (3 papers), Breast Lesions and Carcinomas (3 papers) and BRCA gene mutations in cancer (2 papers). Kendall Walsh is often cited by papers focused on Breast Cancer Treatment Studies (3 papers), Breast Lesions and Carcinomas (3 papers) and BRCA gene mutations in cancer (2 papers). Kendall Walsh collaborates with scholars based in United States. Kendall Walsh's co-authors include Richard L. White, Terry Sarantou, Danielle Boselli, Joshua S. Hill, Jonathan C. Salo, Teresa Flippo‐Morton, Meghan R. Forster, Russell C. Kirks, Yimei Han and Roshan S. Prabhu and has published in prestigious journals such as Journal of Clinical Oncology, Antimicrobial Agents and Chemotherapy and Annals of Surgical Oncology.

In The Last Decade

Kendall Walsh

15 papers receiving 292 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kendall Walsh United States 10 125 106 84 42 39 16 297
H. Frick Switzerland 7 276 2.2× 71 0.7× 80 1.0× 107 2.5× 33 0.8× 10 392
M H Gail United States 8 158 1.3× 174 1.6× 25 0.3× 43 1.0× 32 0.8× 12 447
Manuela Maspoli Switzerland 9 311 2.5× 72 0.7× 25 0.3× 112 2.7× 48 1.2× 14 458
Ali Sakhdari Canada 12 163 1.3× 34 0.3× 26 0.3× 65 1.5× 26 0.7× 37 588
Ada B. Chabon United States 8 132 1.1× 145 1.4× 169 2.0× 144 3.4× 27 0.7× 10 426
A. Rueda Spain 10 102 0.8× 39 0.4× 14 0.2× 61 1.5× 59 1.5× 28 303
Stefanos G. Millas United States 12 241 1.9× 240 2.3× 33 0.4× 20 0.5× 60 1.5× 20 711
Lone Larsen Denmark 12 49 0.4× 133 1.3× 53 0.6× 7 0.2× 35 0.9× 36 442
Michael Castro United States 9 114 0.9× 51 0.5× 63 0.8× 79 1.9× 89 2.3× 28 277
Ntokozo Ndlovu Zimbabwe 11 201 1.6× 50 0.5× 24 0.3× 39 0.9× 46 1.2× 42 362

Countries citing papers authored by Kendall Walsh

Since Specialization
Citations

This map shows the geographic impact of Kendall Walsh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kendall Walsh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kendall Walsh more than expected).

Fields of papers citing papers by Kendall Walsh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kendall Walsh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kendall Walsh. The network helps show where Kendall Walsh may publish in the future.

Co-authorship network of co-authors of Kendall Walsh

This figure shows the co-authorship network connecting the top 25 collaborators of Kendall Walsh. A scholar is included among the top collaborators of Kendall Walsh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kendall Walsh. Kendall Walsh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Walsh, Kendall, et al.. (2018). Using patient-reported religious/spiritual concerns to identify patients who accept chaplain interventions in an outpatient oncology setting. Supportive Care in Cancer. 27(5). 1861–1869. 18 indexed citations
2.
Walsh, Kendall, et al.. (2018). Genetic Testing for Hereditary Breast Cancer: The Decision to Decline. The American Surgeon. 84(1). 154–160. 10 indexed citations
3.
Walsh, Kendall, et al.. (2018). Rationale for Mastectomy after Neoadjuvant Chemotherapy. The American Surgeon. 84(1). 126–132. 11 indexed citations
4.
Flippo‐Morton, Teresa, et al.. (2017). Application of ACOSOG Z1071: Effect of Results on Patient Care and Surgical Decision-Making. Clinical Breast Cancer. 18(4). 270–275. 8 indexed citations
5.
Kirks, Russell C., Danielle Boselli, Kendall Walsh, et al.. (2017). Pathologic Complete Response Rates After Neoadjuvant Treatment in Rectal Cancer: An Analysis of the National Cancer Database. Annals of Surgical Oncology. 24(8). 2095–2103. 62 indexed citations
6.
Walsh, Kendall, et al.. (2017). Changes in margin re‐excision rates: Experience incorporating the “no ink on tumor” guideline into practice. Journal of Surgical Oncology. 116(8). 1040–1045. 19 indexed citations
7.
Walsh, Kendall, et al.. (2017). Utilization of primary chemoradiotherapy for anal squamous cell carcinoma in the elderly: An analysis of the NCDB.. Journal of Clinical Oncology. 35(4_suppl). 726–726. 1 indexed citations
8.
Walsh, Kendall, Yimei Han, Meghan R. Forster, et al.. (2017). Reporting of mitotic rate in cutaneous melanoma: A study using the national cancer data base. Journal of Surgical Oncology. 115(3). 281–286. 6 indexed citations
9.
Kirks, Russell C., Imran Siddiqui, Kendall Walsh, et al.. (2016). Readmission rates of patients undergoing liver directed therapy for metastatic colorectal cancer: An analysis of SEER-medicare. HPB. 18. e194–e195. 1 indexed citations
10.
White, Richard L., Kendall Walsh, Yimei Han, et al.. (2016). Pediatric and Adolescent Melanoma: A National Cancer Data Base Update. Annals of Surgical Oncology. 23(12). 4058–4066. 32 indexed citations
11.
Walsh, Kendall, Russell C. Kirks, Yimei Han, et al.. (2016). Frequency of unplanned surgical intervention in patients with stage IV colorectal cancer receiving palliative chemotherapy: An analysis of SEER-Medicare.. Journal of Clinical Oncology. 34(4_suppl). 640–640.
12.
Huntington, Ciara R., Kendall Walsh, Yimei Han, Jonathan C. Salo, & Joshua S. Hill. (2015). National Trends in Utilization of Endoscopic Ultrasound for Gastric Cancer: a SEER-Medicare Study. Journal of Gastrointestinal Surgery. 20(1). 154–164. 3 indexed citations
13.
Flippo‐Morton, Teresa, et al.. (2015). Surgical Decision Making in the BRCA-Positive Population: Institutional Experience and Comparison with Recent Literature. The Breast Journal. 22(1). 35–44. 30 indexed citations
14.
Abe, Shoko, Joshua S. Hill, Yimei Han, et al.. (2015). Margin re‐excision and local recurrence in invasive breast cancer: A cost analysis using a decision tree model. Journal of Surgical Oncology. 112(4). 443–448. 48 indexed citations
15.
Wohl, David A., Carl J. Fichtenbaum, Thomas Campbell, et al.. (2013). Comparison of Cardiovascular Disease Risk Markers in HIV-Infected Patients Receiving Abacavir and Tenofovir: The Nucleoside Inflammation, Coagulation and Endothelial Function (Nice) Study. Antiviral Therapy. 19(2). 141–147. 35 indexed citations
16.
Wohl, David A., Julie B. Dumond, Ruili Wang, et al.. (2012). Raltegravir Pharmacokinetics in Treatment-Naive Patients Is Not Influenced by Race: Results from the Raltegravir Early Therapy in African-Americans Living with HIV (REAL) Study. Antimicrobial Agents and Chemotherapy. 57(2). 784–788. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026